Featured Posts
BOSTON, MA — October 15, 2025 — Broad Clinical Labs (BCL), in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, today announced official recognition by Guinness World Records for...Read More
At Broad Clinical Labs (BCL), the journey from an idea to a working product often involves people who bridge science, technology, and customer needs. One of those people is Matthew...Read More
At Broad Clinical Labs (BCL), our people are at the core of everything we do. Their expertise and dedication are what make it possible to advance cutting-edge science and deliver...Read More
Mass General Brigham Launches Genetic Test to Predict Risk Across Eight Cardiovascular Conditions Boston, MA – September 3,2025 — In a step forward for genomic-driven preventive medicine, Mass General Brigham...Read More
At Broad Clinical Labs (BCL), science moves with collaboration. Carrie, our Director of Cancer Genomics, has spent over two decades at the forefront of genomics, helping shape landmark discoveries and...Read More
In a pioneering collaboration aimed at transforming pediatric cancer diagnostics and research, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have announced the formation of BrightSeq—Boston Research in...Read More
Everygene, a precision health company dedicated to expanding access to genetic insights for families affected by inherited disease, today announced the launch of a nationwide, no-cost genetic testing program for...Read More
Galatea Bio and Fabric Genomics, a GeneDx company, announced a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to...Read More
Roche announced today a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche’s recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology. This collaboration...Read More
Mass General Brigham Launches Genetic Test to Predict Risk Across Eight Cardiovascular Conditions Boston, MA – September 3,2025 — In a step forward for genomic-driven preventive medicine, Mass General...
In a pioneering collaboration aimed at transforming pediatric cancer diagnostics and research, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have announced the formation of BrightSeq—Boston Research...
Everygene, a precision health company dedicated to expanding access to genetic insights for families affected by inherited disease, today announced the launch of a nationwide, no-cost genetic testing program...
Galatea Bio and Fabric Genomics, a GeneDx company, announced a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to...
Roche announced today a strategic collaboration with Broad Clinical Labs to develop and pilot groundbreaking applications using Roche’s recently unveiled next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology. This...
The goal of developing a 5 billion single-cell atlas within the next three years took a big step forward with the recent announcement of a new effort between longstanding...